Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan J Thompson

Showing results (181-190 of 200) with videos related to

Pageof 20
Sort By:
Cerebral Cortex (New York, N.Y. : 1991)|August 27, 2005
The evolution of prefrontal inputs to the cortico-pontine system: diffusion imaging evidence from Macaque monkeys and humansNarender Ramnani, Timothy E J Behrens, Heidi Johansen-Berg, et al.
Annals of Neurology|March 10, 2011
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteriaChris H Polman, Stephen C Reingold, Brenda Banwell, et al.
Human Brain Mapping|November 27, 2008
Abnormal connectivity of the sensorimotor network in patients with MS: a multicenter fMRI studyMaria A Rocca, Martina Absinta, Paola Valsasina, et al.
Annals of Neurology|November 28, 2024
Towards a Unified Set of Diagnostic Criteria for Multiple SclerosisWallace J Brownlee, Angela Vidal-Jordana, Madiha Shatila, et al.
Nature Medicine|August 20, 2025
AI-driven reclassification of multiple sclerosis progressionHabib Ganjgahi, Dieter A Häring, Piet Aarden, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 15, 2013
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonistsGareth Pryce, Cristina Visintin, Sreeram V Ramagopalan, et al.
Trials|March 4, 2011
The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessmentsPeter Connick, Madhan Kolappan, Rickie Patani, et al.
BMJ Open|September 25, 2025
Single-centre, prospective cohort to predict optimal individualised treatment response in multiple sclerosis (POINT-MS): a cohort profileRonja Christensen, Alessandro Cruciani, Sarmad Al-Araji, et al.
Nature Communications|May 12, 2026
Anti-Nogo-A NG101 treatment induces changes in spinal cord micro- and macrostructure following spinal cord injuryLynn Farner, Paulina S Scheuren, Kiomars Sharifi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2021
Charting a global research strategy for progressive MS-An international progressive MS Alliance proposalAlan J Thompson, William Carroll, Olga Ciccarelli, et al.
Pageof 20

Showing results (181-190 of 200) with videos related to

Sort By:
Pageof 20
Cerebral Cortex (New York, N.Y. : 1991)|August 27, 2005
The evolution of prefrontal inputs to the cortico-pontine system: diffusion imaging evidence from Macaque monkeys and humansNarender Ramnani, Timothy E J Behrens, Heidi Johansen-Berg, et al.
Annals of Neurology|March 10, 2011
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteriaChris H Polman, Stephen C Reingold, Brenda Banwell, et al.
Human Brain Mapping|November 27, 2008
Abnormal connectivity of the sensorimotor network in patients with MS: a multicenter fMRI studyMaria A Rocca, Martina Absinta, Paola Valsasina, et al.
Annals of Neurology|November 28, 2024
Towards a Unified Set of Diagnostic Criteria for Multiple SclerosisWallace J Brownlee, Angela Vidal-Jordana, Madiha Shatila, et al.
Nature Medicine|August 20, 2025
AI-driven reclassification of multiple sclerosis progressionHabib Ganjgahi, Dieter A Häring, Piet Aarden, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 15, 2013
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonistsGareth Pryce, Cristina Visintin, Sreeram V Ramagopalan, et al.
Trials|March 4, 2011
The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessmentsPeter Connick, Madhan Kolappan, Rickie Patani, et al.
BMJ Open|September 25, 2025
Single-centre, prospective cohort to predict optimal individualised treatment response in multiple sclerosis (POINT-MS): a cohort profileRonja Christensen, Alessandro Cruciani, Sarmad Al-Araji, et al.
Nature Communications|May 12, 2026
Anti-Nogo-A NG101 treatment induces changes in spinal cord micro- and macrostructure following spinal cord injuryLynn Farner, Paulina S Scheuren, Kiomars Sharifi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 1, 2021
Charting a global research strategy for progressive MS-An international progressive MS Alliance proposalAlan J Thompson, William Carroll, Olga Ciccarelli, et al.
Pageof 20